Atlas Trials

CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients

Clinical trial NCT04906213 · TERMINATED

Trial details

NCT number
NCT04906213
Sponsor
Duke University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Transplant; ComplicationsDiabetes Mellitus, Type 2
Start date
2022-07-25
Primary completion
2026-01-22
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.